557 related articles for article (PubMed ID: 11523929)
1. A comparison of the patterns of laminin expression in fibroadenoma, fibrocystic diseases, pre-invasive and invasive ductal breast carcinoma.
Zheng WQ; Looi LM; Cheah PL
Pathology; 2001 Aug; 33(3):303-6. PubMed ID: 11523929
[TBL] [Abstract][Full Text] [Related]
2. Loss of types XV and XIX collagen precedes basement membrane invasion in ductal carcinoma of the female breast.
Amenta PS; Hadad S; Lee MT; Barnard N; Li D; Myers JC
J Pathol; 2003 Mar; 199(3):298-308. PubMed ID: 12579531
[TBL] [Abstract][Full Text] [Related]
3. Costimulatory molecule OX40/OX40L expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
Xie F; Wang Q; Chen Y; Gu Y; Mao H; Zeng W; Zhang X
Pathol Res Pract; 2010 Nov; 206(11):735-9. PubMed ID: 20634005
[TBL] [Abstract][Full Text] [Related]
4. [Immunocytochemical detection of laminin by light and electron microscopy: study of changes in the basement membrane in tumor pathology].
Charpin C; Lissitzky JC; Kopp F; Jacquemier J; Lavaut MN; Pourreau-Schneider N; Martin PM; Toga M
Ann Pathol; 1985; 5(2):77-84. PubMed ID: 3899129
[TBL] [Abstract][Full Text] [Related]
5. Morphological aspects of altered basement membrane metabolism in invasive carcinomas of the breast and the larynx.
Nerlich AG; Lebeau A; Hagedorn HG; Sauer U; Schleicher ED
Anticancer Res; 1998; 18(5A):3515-20. PubMed ID: 9858933
[TBL] [Abstract][Full Text] [Related]
6. The phosphorylated form of connexin43 is up-regulated in breast hyperplasias and carcinomas and in their neoformed capillaries.
Gould VE; Mosquera JM; Leykauf K; Gattuso P; Dürst M; Alonso A
Hum Pathol; 2005 May; 36(5):536-45. PubMed ID: 15948121
[TBL] [Abstract][Full Text] [Related]
7. Gene expression and protein deposition of major basement membrane components and TGF-beta 1 in human breast cancer.
Nerlich AG; Wiest I; Wagner E; Sauer U; Schleicher ED
Anticancer Res; 1997; 17(6D):4443-9. PubMed ID: 9494547
[TBL] [Abstract][Full Text] [Related]
8. Localization of mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase type II in human breast and its disorders.
Sasano H; Frost AR; Saitoh R; Matsunaga G; Nagura H; Krozowski ZS; Silverberg SG
Anticancer Res; 1997; 17(3C):2001-7. PubMed ID: 9216657
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical study of TGF-alpha, TGF-beta1, EGFR, and IGF-1 expression in human breast carcinoma.
Pilichowska M; Kimura N; Fujiwara H; Nagura H
Mod Pathol; 1997 Oct; 10(10):969-75. PubMed ID: 9346175
[TBL] [Abstract][Full Text] [Related]
10. Detection of basement membrane components and basal cell keratin 14 in noninvasive and invasive carcinomas of the breast.
Wetzels RH; Holland R; van Haelst UJ; Lane EB; Leigh IM; Ramaekers FC
Am J Pathol; 1989 Mar; 134(3):571-9. PubMed ID: 2466404
[TBL] [Abstract][Full Text] [Related]
11. Laminin production and fibronectin immunoreactivity in breast carcinomas.
Gorczyca W; Holm R; Nesland JM
Anticancer Res; 1993; 13(4):851-8. PubMed ID: 8394677
[TBL] [Abstract][Full Text] [Related]
12. Proliferating cell nuclear antigen (PCNA) expression in patients with breast carcinoma in comparison to patients with benign breast diseases.
Kalogeraki A; Tzardi M; Datseris G; Kanavaros P; Karvelas C; Chalkiadakis G; Tsiftsis D; Delides G
In Vivo; 1994; 8(6):1053-6. PubMed ID: 7772736
[TBL] [Abstract][Full Text] [Related]
13. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.
Shin SJ; Simpson PT; Da Silva L; Jayanthan J; Reid L; Lakhani SR; Rosen PP
Am J Surg Pathol; 2009 Apr; 33(4):496-504. PubMed ID: 19047897
[TBL] [Abstract][Full Text] [Related]
14. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
de Candia P; Akram M; Benezra R; Brogi E
Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
[TBL] [Abstract][Full Text] [Related]
15. Lectin binding patterns in benign and malignant lesions of the breast.
Karuna V; Shanthi P; Madhavan M
Indian J Pathol Microbiol; 1992 Oct; 35(4):289-97. PubMed ID: 1344218
[TBL] [Abstract][Full Text] [Related]
16. CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
Bircan S; Kapucuoglu N; Baspinar S; Inan G; Candir O
Pathol Res Pract; 2006; 202(8):569-76. PubMed ID: 16828238
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of E-cadherin in sclerosing adenosis, ductal carcinoma in situ and invasive ductal carcinoma of the breast.
Facina G; Lopes-Costa PV; Dos Santos AR; De Vasconcelos-Valença RJ; Pinho-Sobral AL; Ferreira-Filho CP; Alencar AP; Gebrim LH; Da Silva BB
Diagn Cytopathol; 2010 Apr; 38(4):235-8. PubMed ID: 19790246
[TBL] [Abstract][Full Text] [Related]
18. The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast.
Latta EK; Tjan S; Parkes RK; O'Malley FP
Mod Pathol; 2002 Dec; 15(12):1318-25. PubMed ID: 12481013
[TBL] [Abstract][Full Text] [Related]
19. The spectrum of 67-kD laminin receptor expression in breast carcinoma progression.
Viacava P; Naccarato AG; Collecchi P; Ménard S; Castronovo V; Bevilacqua G
J Pathol; 1997 May; 182(1):36-44. PubMed ID: 9227340
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the pattern of cathepsin-D expression in fibroadenoma, fibrocystic disease, preinvasive and invasive ductal breast carcinoma.
Zheng WQ; Looi LM; Cheah PL
Pathology; 1999 Aug; 31(3):247-51. PubMed ID: 10503271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
